illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Sedana Medical
Company logo

Sedana Medical | Sustainability Performance

https://sedanamedical.com
Linkedin

Sedana Medical specializes in developing and providing medical devices for the delivery of anesthesia gases. The company focuses on enhancing safety and efficacy in sedation practices, primarily targeting the needs of healthcare professionals within the field.

1951

Sweden

51 - 200 employees

Medical Device

$10M - 25M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#2328
Overall
#155
in Sweden
#35
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Moberg Pharma

Sweden, Hospital & Health Care, Pharmaceuticals


Company logo
Recipharm

Sweden, Hospital & Health Care, Pharmaceuticals


Company logo
RaySafe

Sweden, Hospital & Health Care, Medical Device

Market cap

11.2B $, 2026▼27.9% YoY

Revenue

20.4M $, 2025▲11% YoY

R&D intensity

10% 2025

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Sedana Medical's AnaConDa inhalation sedation device faced clinical scrutiny regarding optimal dosing protocols and patient monitoring requirements.
Powered by illuminem

Market cap

11.2B $, 2026▼27.9% YoY

Revenue

20.4M $, FY2025▲11% YoY

EBITDA

-3.3M $, FY2025▼9.1% YoY

Operating margin

-16% Industry: -136▼76.8% YoY

Revenue & EBITDA

$20.4MFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-19.0M 2024▼10.8% YoY

Capex

17.8M 2024▲4% YoY

Debt/equity ratio

0.0 Industry: 1▼NaN% YoY

R&D intensity

10.0%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

-7.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.0

▲ 3.0%

2023

0.0

▼ 0.3%

2024

0.0

▲ 0.3%

2025

0.3

2028

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

42%
Independent Directors

5 out of 12 incl. management

Powered by illuminem

Overall score

53

Environment

65

Social

51

Governance

43

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

image report
Available

Sustainability employees


Total sustainability employees

2-3



    Available in
    Scale package

    Access
  • Email

  • Email